homeostasis leads to several clinical symptoms such as muscle stiffness and seizures. 1 The study of clinical and genetic conditions related to hypomagnesemic states have given a better understanding of how the Mg 2 þ balance is regulated by the human body, demonstrating an instrumental role of the kidney. The human kidney filters B2400 mg of Mg 2 þ per day, and reclaims B95% of the filtered Mg 2 þ load. 2, 3 The regulation of Mg 2 þ reabsorption throughout the nephron allows the kidney to respond to changes in Mg 2 þ balance and thereby keeps plasma Mg 2 þ levels within the normal range. 1 The distal convoluted tubule (DCT) is the major site of active transcellular Mg 2 þ reabsorption. 4 The apical uptake of Mg 2 þ in this segment is mediated via the transient receptor potential melastatin 6 (TRPM6) channel [5] [6] [7] and the apical Shaker-like voltage-dependent K þ channel member 1 (Kv1.1). 8 The KCNA1 gene encodes for Kv1.1, being expressed in several organs including heart and smooth muscle, kidney, or brain, where it has been associated with episodic ataxia type-1, a pathological condition in which patients suffer from constant muscle rippling movements and episodic attacks of ataxia. 9 In contrast to Na þ (NaV) or Ca 2 þ (CaV) voltage-dependent channels, Kv channels are not arranged in a single contiguous polypeptide containing four repeated domains, but consist of four different subunits that are clustered to form the ion permeation pathway across the membrane. 10, 11 Each of these subunits contains six a-helical transmembrane segments, where the fourth segment incorporates multiple positive charged amino acids (arginines) responsible for sensing changes in membrane potential, the so-called voltage sensor. 12 Recently, we described a key role for Kv1.1 in renal Mg 2 þ transport. 8 In a large family with isolated autosomal dominant hypomagnesemia due to renal Mg 2 þ wasting, a mutation in Kv1.1 was identified as the causative factor. The Kv1.1 N255D missense mutation resulted in the loss of channel function in a dominant manner. Immunohistochemical studies showed luminal expression of Kv1.1 in DCT segments, where it colocalized with TRPM6. 8 Its location and function in addition to the phenotype observed in affected patients suggests a key role in epithelial Mg 2 þ transport. The Kv1.1 channel is involved in establishing a favorable electrical gradient to drive Mg 2 þ transport into the DCT cell via TRPM6. As the apical influx of Mg 2 þ in DCT is suggested to largely depend on this electrical gradient, the absence of Kv1.1 is likely to depolarize the apical membrane, and it, thereby, impairs the establishment of a favorable driving force for Mg 2 þ entry. At present, little is known about the molecular mechanisms regulating the function of Kv1.1 within the kidney. In general, the cytoplasmic terminal domains have a critical role in regulating the biophysical properties of ion channels and transporters. 13, 14 We, therefore, used the carboxy (C)-terminal domain of Kv1.1 to screen mouse kidney lysates for novel binding partners that could modulate Kv1.1 function in the kidney, and hence Mg 2 þ transport in the DCT. The identified binding partners were subsequently characterized by immunohistological, cell physiological, and patch-clamp analyses.
RESULTS

ANK3 as new Kv1.1-associated protein
A proteomic approach was used to identify novel binding partners that can modulate Kv1.1 activity in the kidney and thereby modify Mg 2 þ transport in DCT. Using the C-terminal domain of Kv1.1 coupled to glutathione Stransferase (GST) pearls as bait, co-immunoprecipitation and pull-down assays were performed on mouse kidney lysates and subsequently analyzed by mass spectrometry to screen for potential candidates. A script developed in-house was used to perform protein validation. The taxonomy of protein identifications was based on the number of uniquely identified sequences of a specific peptide, and/or clusters of proteins sharing the same set of peptides. All the binding partners identified were validated. The identified proteins were aligned at the NCBI (National Center for Biotechnology Information) databank to generate accession numbers and names for each protein, and detailed information on the protein can be found in www.ncbi.nlm.nih.gov as stated. Figure 1a shows a summary of the identified potential binding partners of Kv1.1. Selection of candidates for further analysis was based on positive localization in DCT. DCTenriched isolates from Complex Parametric Analyzer and Sorter (COPAS)-sorted tubules, 15 expressing enhanced green fluorescent protein (eGFP) after the parvalbumin promoter, showed increased mRNA expression of ankyrin-3 (ANK3) when compared with total kidney. Solute carrier family 2 and 3, which are ubiquitously expressed in kidney, were not enriched in these samples (Figure 1b) . Known DCT-specific markers such as parvalbumin, thiazide-sensitive NaCl cotransporter, and TRPM6 were also enriched in DCT isolates. 15 Subsequently, the interaction between ANK3 and Kv1.1 was confirmed by co-immunoprecipitation experiments. Coexpression of GST-labeled Kv1.1 C-tail with hemagglutinin-tagged ANK3 showed strong interaction (Figure 1c) .
ANK3 decreases Kv1.1 activity
To examine whether the Kv1.1-interacting candidate ANK3 could modulate the channel function, we used the whole-cell patch-clamp technique in human embryonic kidney 293 (HEK293) cells transiently transfected with both proteins. Activation of the ion channel via the application of a series of depolarizing voltage steps elicited outward rectifying currents resembling the main biophysical characteristics of Kv1.1, that is, a fast delayed activation and slowly inactivating kinetics. These currents were absent in mock-transfected HEK293 cells (Figure 2a ). Cells were clamped at a holding potential of À 80 mV, and currents were elicited by the application of a family of voltage steps in 200-ms intervals, from À 80 mV to þ 50 mV in 10-mV increments. Tail currents were recorded at À 80 mV by using a high K þ extracellular solution. Coexpression of ANK3 produced a significant reduction of the outward currents mediated by Kv1.1, when depolarizing voltage steps were applied (Figure 2a ). This was also apparent from the averaged I-V relation curves (Figure 2b and c). Averaged Kv1.1 current densities were significantly reduced by ANK3 (267 ± 28 and 125 ± 20 pA/pF in the absence and presence of ANK3, respectively, Po0.05; Figure 2c ). Because the voltage sensitivity of Kv1.1 was significantly affected by ANK3, we obtained the curve for the voltage dependence of activation (G-V). By using the steady-state ionic currents evoked with our voltage step protocol, we confirmed that coexpression of ANK3 was accompanied by a decrease in Kv1.1 conductance from 3.1±0.4 to 1.2±0.1 nS (Figure 2d ). However, analysis of normalized conductance (G/G max ) did not reveal a significant difference in the voltage requirement for channel activation (V 0.5 ): À 31.1±0.6 compared with À 32.3 ± 1.1 mV in the absence and presence of ANK3, respectively (P40.2; Figure 2e ). These results suggest that ANK3 decreases the open probability of Kv1.1 by impeding the flow of ions through the channel, possibly by stabilizing a closed state of the functional unit in the plasma membrane. In addition, the reversal membrane potential in HEK293 cells expressing Kv1.1 potassium channels, as well as coexpressing ANK3, was measured to investigate the possible modulatory effect of ANK3 on channel activity. Expression of Kv1.1 resulted in a reversal potential of À 36.8±1.1 mV (n ¼ 51) compared with þ 16.4 ± 8.7 mV (n ¼ 10) in mock-transfected HEK293 cells. A small, although significant (Po0.05), shift to more depolarized membrane potential was demonstrated in the presence of ANK3 À 32.8 ± 1.6 mV (n ¼ 30).
We analyzed the Kv1.1 time course of activation and inactivation parameters to investigate whether additional biophysical properties of Kv1.1 were affected by the interaction with ANK3 ( Figure 3 ). The time constants of both processes were determined from fitting exponential functions to the relevant currents. This revealed no difference in the activation kinetics of Kv1.1 when it was coexpressed with ANK3 ( Figure 3a-d) . Fit of the rising phase of currents yielded time constants of 16.4 ± 0.6 ms in the absence compared with 17 ± 1.1 ms in the presence of ANK3. When evaluating the deactivation kinetics of the channel in the presence of ANK3, we found an increased deactivation rate (Figure 3e ), suggesting that ANK3 slightly slows the process by which the channels relax towards the resting state. We also examined C-type inactivation properties in both conditions by using a holding membrane potential of À 80 mV and then applying depolarizing prepulses to the cell ranging from À 90 to þ 30 mV. Overlay of the resulting inactivation curves did not give significant differences with time constants of 12.6 ± 1.3 and 15.4 ± 1.7 ms in the absence and presence of ANK, respectively (P40.2; Figure 4a -d). Our functional results suggest that ANK3 acts by modulating the open probability of the channel, potentially by stabilizing a closed state, affecting the transition between the activated and resting states of the ion channel. An overview of the electrophysiological characteristics of Kv1.1 in the presence or absence of ANK3 can be found in Table 1. ANK3 does not affect the abundance of Kv1.1 at the plasma membrane ANK3 expression produced a significant reduction in the density current of Kv1.1 after application of depolarizing voltage steps. To confirm that ANK3 is affecting Kv1.1-mediated conductance and not modulating its cell surface expression by altering trafficking events, we performed cell surface biotinylation in the presence and absence of ANK3. Figure 5 shows that Kv1.1 is present at the plasma membrane, but also that its presence on the plasma membrane is not affected by ANK3. Our results support the hypothesis that the observed reduction in Kv1.1-mediated outward currents is a consequence of altered biophysical properties rather than changes in the number of channels in the membrane. Mice exposed to a low-Mg 2 þ diet significantly increased their renal TRPM6 expression (Figure 7a) , as reported previously. 16 Importantly, mice fed a high-Mg 2 þ diet showed a significant increase in the expression of renal ANK3 compared with normal or low diet (Figure 7b ). These observations suggest that ANK3 may have a key role in regulating Kv1.1 during conditions of Mg 2 þ loading by further reducing the renal reabsorptive capacity for the cation. Furthermore, mice fed the high-Mg 2 þ diet exhibited a significant decrease in the expression of renal Kv1.1 (compared with normal Mg 2 þ ), as well as a significant increase in the expression of renal Kv1.1 during conditions of low-Mg 2 þ diet, depicting the importance of Kv1.1 regulation in Mg 2 þ homeostasis (Figure 7c ).
DISCUSSION
Important progress has been made in recent years with regard to the identification of molecular candidates involved in the 
7.2 ± 0.9 6.9 ± 0.9 adequate electrical environment to favor Mg 2 þ entry via TRPM6. ANK3 could, in turn, be involved in modulating the inward electrochemical driving force for Mg 2 þ by modifying Kv1.1 gating.
In the kidney, K þ channels are expressed throughout the nephron. However, only few of them are directly involved in renal K þ transport, whereas others are likely to support alternative functions. 8, [18] [19] [20] [21] Kv1.1 is a K þ ion channel present in the luminal membrane of the DCT, where it establishes a favorable electrochemical driving force for Mg 2 þ entry across the plasma membrane. Similar to several ion channels, Kv1.1 is probably regulated by cytoplasmic proteins. From our set of candidates binding to the C-terminal domain of Kv1.1, ANK3 was found to be the most interesting candidate owing to its apparent enrichment in DCT. Ankyrins are adaptor proteins that link the spectrin/actin network to the cytoplasmic domain of membrane proteins, including ion channels and cell adhesion molecules. 22, 23 Several studies have suggested that ankyrins have an important role in maintaining membrane proteins at their cellular location to optimize or modulate their function. Ankyrins are localized in specialized plasma membrane domains such as basolateral domains of epithelial tissues, neuromuscular junctions, nodes of Ranvier, and axon initial segments. [24] [25] [26] [27] [28] Ankyrins have been found to interact in vitro with ion channels and transporters, such as the voltage-dependent Na þ channel and the Na þ /K þ -ATPase that are targeted to the same cell surface domains containing ankyrin. [29] [30] [31] In line with these studies, we would like to propose an important role for ANK3 in Kv1.1 function by targeting Kv1.1 to the apical side of DCT cells.
ANK3 has been shown to interact with K þ voltage-gated channels including the KQT-like subfamily member 2 (KCNQ2), as well as the voltage-gated Na þ channel member 1.5 (NaV1.5) in the central nervous system. 32, 33 Moreover, ANK3 binding to Nav1.5 affects its voltage dependence of activation and kinetics of inactivation. 29 Although ankyrinbinding motifs are not present in the Kv1.1 channel, we confirmed the interaction by co-immunoprecipitations using the GST-tagged C-terminus of Kv1.1 and hemagglutinintagged ANK3 transiently expressed in HEK293 cell lysates. Whether ANK3 binds the Kv1.1 channel directly or rather indirectly with the involvement of other proteins in a macromolecular complex is not clear at present. This latter possibility is interesting, as growing evidence suggests that interacting proteins are important to ion channel clustering and function in the plasma membrane. Membranous macromolecular complexes mediate intracellular signaling cascades, where scaffolding protein orchestrates the arrangement of complexes including key factors such as kinases, phosphatases, and cytoskeleton. 34 Ankyrin proteins interact with the cytoplasmic protein including tubulin, 35 supporting an important role in these macromolecular complexes. Binding of ANK3 to Kv1.1 resulted in a reduction of the ensemble current, most likely by affecting the channel open probability (P 0 ) rather than influencing its voltage dependence or the number of channels at the plasma membrane. This conclusion is supported by the observed reduction in Kv1.1 conductance in the presence of ANK3.
Quantitative analysis of currents revealed a significant twofold decrease in the voltage response, potentially through modulating the gating of the channel, as shown by the significant reduction in Kv1.1 conductance. Furthermore, other Kv1.1 biophysical properties such as activation and C-type inactivation kinetics remained unchanged, suggesting that ANK3 may represent a Kv1.1-interacting subunit regulating Mg 2 þ reabsorption via inhibition of ion channel activity. Furthermore, our results support the idea that the C-terminus of Kv1.1 may be relevant to regulate the gating properties of the K þ channel analogous to the Kvb1-subunit modulating the inactivation rate via its N-terminus and, therefore, adding an additional feature to control channel activity.
Overall, our data suggest that under low dietary Mg 2 þ conditions, Mg 2 þ reabsorption is enhanced when Kv1.1 (NP 0 ) is increased. This assumption is supported by an increase in Kv1.1 mRNA expression accompanied by control levels of ANK3 mRNA, thus keeping Kv1.1 (NP 0 ) high (Figure 7a and b) . In this way, a maximal Mg 2 þ reabsorption rate could be achieved. Figure 7c shows a significant increase in Kv1.1 mRNA, and thus Kv1.1 plasma membrane expression is enhanced. Our metabolic data shown in Figure 6a and b are consistent with the former explanation. Mice placed on a high-Mg 2 þ diet show an attenuated Mg 2 þ reabsorption when NP 0 of Kv1.1 is decreased, which may attenuate TRPM6 activity as well, as a consequence of a decrease in the driving force for Mg 2 þ reabsorption. Furthermore, the mRNA expression levels show some additional reduction, reinforcing this hypothesis. Moreover, Figure 7b displays that ANK3 levels increase, pointing to a decreased NP 0 of Kv1.1 (confirmed by our patch-clamp data). Taken together, this study demonstrates a novel role for ANK3 in modulating the biophysical properties of Kv1.1. in response to dietary Mg 2 þ .
MATERIALS AND METHODS
Pull-down and mass spectrometry assays Pull-down assays were performed on mouse kidney lysates using the C-terminal domain of human Kv1.1 (amino acids 408-495) coupled to GST as bait. Recombinant protein was produced in Escherichia coli BL21 cells. The bacteria were lysed and the GST-Kv1.1 C-terminal domain was purified on glutathione-Sepharose beads (Amersham Pharmacia Biotech; GE Healthcare Life Sciences, Piscataway, NJ). C57BL/6 mice were killed by cervical dislocation under deep anesthesia (4.5% (v/v) isofluorane anesthesia; Nicholas Piramal, London, UK), and the kidneys were homogenized in lysis buffer (20 mmol/l Tris-HCl, pH ¼ 7.4, 140 mmol/l NaCl, 1 mmol/l CaCl 2 , 0.2% (v/v) Triton X-100, and 0.2% (v/v) NP-40) containing protease inhibitors (0.10 mg/ml leupeptin, 0.05 mg/ml pepstatin-A, 1 mmol/l phenylmethylsulfonyl fluoride, and 5 mg/ml aprotinin). The precipitated GST-terminal proteins were incubated overnight at 4 1C with mouse kidney lysates. Resultant eluted precipitates were identified by mass spectrometry by the Nijmegen Proteomics Facility (Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands). In brief, samples were digested after reduction and alkylation. The digested samples were loaded on stage tips for desalting and concentration, and were eluted in a final volume of 20 ml, of which 8 ml was used for an extra strong cation exchange purification step to remove contaminants. The resulting peptide mixture was resolved by reverse-phase nano-high-performance liquid chromatography before nanoelectrospray ionization. Peptide ions were analyzed by the LTQ FT Ultra MS mass spectrometer (Thermo Fisher Scientific, San Jose, CA). Peptide and protein identifications were extracted from the data using the search program Mascot (Matrix Science, Boston, MA). In this case, a combined RefSeq36 Mouse/ E.coli K12 database was used with added sequences of the GST-tagged proteins.
COPAS sorting of DCT tubules
Briefly, a renal tubule suspension was obtained from transgenic mice expressing eGFP after the parvalbumin promoter, as described previously. 15 The renal tubules were subsequently sorted by the COPAS into two fractions: an eGFP-enriched fraction (designated as DCT isolates) and the remaining tubules. RNA was isolated from both fractions, and gene expression was compared with the expression in total kidney samples.
Magnesium diets
Male C57BL/6 mice (10 weeks old, n ¼ 30 purchased from Harlan/ CPB, Zeist, The Netherlands) were individually housed in metabolic cages at day 0, enabling 24-h urine collections under mineral oil to prevent evaporation. Subsequently, mice were randomly divided into three groups and fed low (0.005% (wt/wt)), normal (0.19% (wt/wt)), or high (0.48% (wt/wt)) dietary Mg 2 þ for 10 days 36 (Sniff mice diets, Soest, Germany). Animals were kept in a lightand temperature-controlled room with food and water available ad libitum. At the end of the experimental period, mice were again placed in metabolic cages for determination of 24-h urinary Mg 2 þ excretion. Animals were killed by cervical dislocation under deep anesthesia (1.5% v/v isofluorane, Nicholas Piramal). Blood was obtained by perforating the orbital vessels. The kidneys were dissected and snap-frozen in liquid nitrogen. One half of the kidney was immersion-fixed in 2% w/v periodate-lysine-paraformaldehyde and incubated overnight in 15% w/v sucrose in phosphate-buffered saline, as described previously. 37 The tissue was subsequently snapfrozen in liquid nitrogen and further processed for immunohistochemistry. The animal ethics board of the Radboud University Nijmegen approved all animal experiments.
Analytical procedures
Urinary and serum creatinine concentrations were determined by the clinical chemistry department. Urinary Na þ and K þ concentrations were measured by flame spectrophotometry (FCM 6343; Eppendorf, Hamburg, Germany). Urine and serum concentrations of Mg 2 þ were determined using a colorimetric assay kit according to the manufacturer's protocol (Roche Diagnostics, Almere, The Netherlands).
Semiquantitative real-time PCR analysis
To determine mRNA expression of genes involved in Mg 2 þ homeostasis, total RNA was obtained from total kidney or 2000 COPAS-sorted tubules using Trizol Total RNA Isolation Reagent (Life Technologies BRL, Breda, The Netherlands). RNA was DNAsetreated (Promega, Madison, WI). Next, 2 mg of RNA was reversetranscribed by Molony-Murine Leukemia Virus-Reverse Transcriptase (Invitrogen Life Technologies, Breda, The Netherlands) using standard procedures. Before reverse transcriptase quantitative PCR reactions, the efficiency (95-105%) and dynamic range (R 2 40.98) were evaluated for each primer set. Real-time PCR reactions were performed on a Bio-Rad CFX96 Real-Time PCR and Bio-Rad C1000 Thermal Cycler system (Bio-Rad Laboratories, Hercules, CA). Reactions were performed in duplo using 6.25 ml of SYBR-Green Master Mix (Applied Biosystems, Foster City, CA), 12.5 ng of template cDNA, and 400 nmol/l of each primer in a final volume of 12.5 ml. All amplicons showed the correct sizes after gel electrophoresis, and the dissociation curves showed one distinct melting peak, ensuring the absence of a nonspecific byproduct or primer dimers. Moreover, No Reverse Transcription and No Template controls were taken along.
Electrophysiology and solutions HEK293 cells were seeded as previously described. 38 Transient cotransfections were performed using Lipofectamine 2000 reagent (Invitrogen) with hemagglutinin-tagged Kv1.1-pCINeo-IRES-GFP and either empty pCINeo-IRES-GFP (MOCK) or ANK3-pCINeo-IRES-GFP (0.5 mg each). After 48 h, transfected cells were plated on 18-mm glass coverslips coated with fibronectin (Roche Diagnostics).
The whole-cell configuration of the patch-clamp technique was followed using an EPC-9 patch-clamp amplifier controlled by Pulse software (HEKA Elektronik, Pfalz, Germany). Borosilicate patch pipettes (Harvard apparatus, Kent, UK) had resistances between 2 and 3 MO after being filled with an intracellular solution. Series resistances (o10 MO) were monitored after each sweep with the automatic capacitance compensation of Pulse software, without additional compensation throughout the recording. Only cells showing stable series resistance values were further considered for analysis. Experiments were performed at room temperature (21 1C) . For the study of Kv1.1-evoked outward K þ currents, the holding potential (V h ) was held at À 80 mV unless otherwise noted. A voltage-step stimulation protocol consisting of 150-ms depolarizing pulses from À 100 to þ 100 mV in 20 mV increments at intervals of 4 s were applied and used offline to build up the I-V curves. Conductance to voltage curves (G-V) were obtained by converting current values for each voltage step to conductance using the equation G ¼ I / (V À V rev ), where G is conductance, I represents the peak current, V is the command pulse potential, and V rev is the reversal potential of the ionic current obtained from the I-V curve. G-V curves were fitted according to the Boltzmann equation, G ¼ G max / {1 þ exp [(V þ V 0.5 ) / a k ]}, where G max is the maximal conductance, V 0.5 is the voltage required to activate the half-maximal conductance, and a k represents the slope of the G-V curve. To study changes in activation threshold of the channel, conductance at þ 100 mV was used to generate the G/G max versus V curves. The extracellular bath solution consisted of the following (in mmol/l): 150 NaCl, 4 KCl, 2 CaCl 2 , 1 MgCl 2 , and 10 HEPES (pH 7.4 with NaOH). To measure tail currents, a high extracellular K þ solution was used, consisting of the following (in mmol/l): 100 NaCl, 50 KCl, 2 CaCl 2 , 1 MgCl 2 , and 10 HEPES (pH 7.4 with NaOH). Pipettes were filled with a solution consisting of the following (in mmol/l): 144 KCl, 1 EDTA, and 10 HEPES (pH 7.2 with KOH). To obtain a final concentration for CaCl 2 and MgCl 2 of 100 and 1 mmol/l, respectively, the Maxchelator software was used (http:// maxchelator.stanford.edu). The analysis and display of patch-clamp data was performed using the Igor Pro software version 6.0 (WaveMetrics, Lake Oswego, Portland, OR).
Cell surface protein biotinylation HEK293 cells were grown to 60-70% confluence. Before biotinylation, the used medium was discarded, and the transfected cells were rinsed in the cold room (4 1C) with prechilled phosphate-buffered saline twice. EZ-link Sulfo-NHS-LC-Biotin (Pierce Biotechnology, Thermo Scientific, Rockford, IL) at a concentration of 0.5 mg/ml was added to cover the surface of the cell layer (1 ml/6-well plate), and the plates were gently shaken at 4 1C for 30 min. Tris-Cl, pH 7.5, was added to a final concentration of 100 nmol/l to stop the biotinylation reaction. The cells were rinsed with ice-cold phosphate-buffered saline (pH 7.4) twice and then lysed with 500 ml of (1.0% v/v) lysis buffer (NP-40, 150 mmol/l NaCl, 5 mmol/l EDTA, 50 mmol/l Tris, pH 7.5, NaOH). Part of the lysate was used for western blotting to measure the total level of the targeted protein. To purify surface protein, 50 ml of Neutravidin-agarose beads (Pierce Biotechnology, Thermo Scientific) was added and mixed well with the lysate at 4 1C overnight. The beads were then washed five times with phosphatebuffered saline buffer. The cell surface proteins were released by the addition of 30 ml of 1Â SDS-PAGE sample loading buffer (Sigma-Aldrich, Zwijndrecht, The Netherlands), followed by heating at 100 1C for 5 min. Experiments were repeated three independent times. Protein levels were visualized by western blotting using the Fluor-S Max Multi-Imager (Bio-Rad Laboratories). The protein band intensities were quantified using an image acquisition and analyses software Quantity One software (Bio-Rad Laboratories) package.
Statistical analysis
Values are expressed as mean ± s.e.m. Differences between groups were tested by one-way analysis of variance and further evaluated using Fisher's multiple comparisons. Differences in means with Po0.05 were considered statistically significant. All analyses were performed using the Sigma Plot 10.0 (Systat Software (SSI), San Jose, CA) and Statview Statistical Package (SAS Institute, San Francisco, CA).
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